Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
--BofA Securities Adjusts Vaxcyte Price Target to $130 From $133, Maintains Buy Rating

--BofA Securities Adjusts Vaxcyte Price Target to $130 From $133, Maintains Buy Rating

MT newswireMT newswire2026/09/28 11:43
By:MT newswire
07:43 AM EDT, 09/28/2026 (MT Newswires) -- BofA Securities Adjusts Vaxcyte Price Target to $130 From $133, Maintains Buy Rating
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!